Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 195 of 1,261
  1. US 11648287

    Composition for the treatment of intracellular bacterial infection

    ACADEMISCH MEDISCH CENTRUM · Granted May 16, 2023 · Expires May 11, 2043

    granted
  2. US 11648237

    5HT agonists for treating disorders

    The Regents of the University of California · Granted May 16, 2023 · Expires May 11, 2043

    granted
  3. US 11648210

    Compositions and methods for organ specific delivery of nucleic acids

    The Board of Regents of the University of Texas System · Granted May 16, 2023 · Expires May 11, 2043

    granted
  4. US 11648232

    Methods and compositions for treating excessive sleepiness

    AXSOME MALTA LTD. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  5. US 11648211

    Nanoencapsulated combination drug formulations

    Northwestern University · Granted May 16, 2023 · Expires May 11, 2043

    granted
  6. US 11648245

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted May 16, 2023 · Expires May 11, 2043

    granted
  7. US 11649438

    Methods and compositions for treating cancer

    CRISPR THERAPEUTICS AG · Granted May 16, 2023 · Expires May 11, 2043

    granted
  8. US 11649273

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  9. US 11648247

    Compositions and methods for the treatment of presbyopia

    Lenz Therapeutics, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  10. US 11648297

    Bioresponsive particles

    The Board of Regents of the University of Texas System · Granted May 16, 2023 · Expires May 11, 2043

    granted
  11. US 11649209

    Crystalline freebase forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted May 16, 2023 · Expires May 11, 2043

    granted
  12. US 11648302

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted May 16, 2023 · Expires May 11, 2043

    granted
  13. US 11648209

    Compositions and methods for organ specific delivery of nucleic acids

    The Board of Regents of the University of Texas System · Granted May 16, 2023 · Expires May 11, 2043

    granted
  14. US 11647776

    Extract, consumable product and method for enriching bioactive metabolite in an extract

    Brightseed, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  15. US 11648307

    Anti-DC-HIL antibodies for cancer diagnosis, prognosis and therapy

    The Board of Regents of the University of Texas System · Granted May 16, 2023 · Expires May 11, 2043

    granted
  16. US 11649207

    Formulations of T-type calcium channel modulators and methods of use thereof

    PRAXIS PRECISION MEDICINES, INC. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  17. US 11649239

    Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1)

    Medshine Discovery Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  18. US 11649454

    Single-stranded RNA-editing oligonucleotides

    ProQR Therapeutics II B.V. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  19. US 11642331

    Glucocorticoid receptor modulators to treat pancreatic cancer

    Corcept Therapeutics Incorporated · Granted May 9, 2023 · Expires May 4, 2043

    granted
  20. US 11642023

    Hyperspectral imaging for detection of transmissible spongiform encephalopathy

    Regents of the University of Minnesota · Granted May 9, 2023 · Expires May 4, 2043

    granted
  21. US 11642339

    Methods of treating symptoms of gastroparesis using velusetrag

    Theravance Biopharma R&D IP, LLC · Granted May 9, 2023 · Expires May 4, 2043

    granted
  22. US 11642410

    Targeting microbubbles

    The Regents of the University of California · Granted May 9, 2023 · Expires May 4, 2043

    granted
  23. US 11642398

    Factor IX polypeptide formulations

    BIOVERATIV THERAPEUTICS INC. · Granted May 9, 2023 · Expires May 4, 2043

    granted
  24. US 11642379

    Hematopoietic stem cell engraftment

    The Regents of the University of California · Granted May 9, 2023 · Expires May 4, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.